ID   DUS7_HUMAN              Reviewed;         419 AA.
AC   Q16829; Q2M3J7; Q8NFJ0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 4.
DT   15-MAR-2017, entry version 145.
DE   RecName: Full=Dual specificity protein phosphatase 7;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=Dual specificity protein phosphatase PYST2;
GN   Name=DUSP7; Synonyms=PYST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE PROMOTER
RP   USAGE, AND FUNCTION.
RC   TISSUE=Monocyte;
RX   PubMed=14603440; DOI=10.1002/gcc.10295;
RA   Levy-Nissenbaum O., Sagi-Assif O., Witz I.P.;
RT   "Characterization of the dual-specificity phosphatase PYST2 and its
RT   transcripts.";
RL   Genes Chromosomes Cancer 39:37-47(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-235 (ISOFORM 1).
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 83-419 (ISOFORM 1).
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 149-419 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=8670865;
RA   Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., Keyse S.M.;
RT   "Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1,
RT   a novel cytosolic dual-specificity phosphatase.";
RL   EMBO J. 15:3621-3632(1996).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=14576828; DOI=10.1038/sj.onc.1206971;
RA   Levy-Nissenbaum O., Sagi-Assif O., Kapon D., Hantisteanu S., Burg T.,
RA   Raanani P., Avigdor A., Ben-Bassat I., Witz I.P.;
RT   "Dual-specificity phosphatase Pyst2-L is constitutively highly
RT   expressed in myeloid leukemia and other malignant cells.";
RL   Oncogene 22:7649-7660(2003).
CC   -!- FUNCTION: Regulates the activity of the MAP kinase family in
CC       response to changes in the cellular environment. PYST2-S may act
CC       as a negative regulator of PYST2-L although it is unclear whether
CC       this is by competing for transcription, translation or activation
CC       factors. {ECO:0000269|PubMed:14603440}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- INTERACTION:
CC       P10912:GHR; NbExp=2; IntAct=EBI-1265847, EBI-286316;
CC       O43791:SPOP; NbExp=5; IntAct=EBI-1265847, EBI-743549;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1; Synonyms=PYST2-L;
CC         IsoId=Q16829-1; Sequence=Displayed;
CC       Name=2; Synonyms=PYST2-S;
CC         IsoId=Q16829-2; Sequence=VSP_012822;
CC   -!- TISSUE SPECIFICITY: Expressed at significantly higher levels in
CC       malignant hematopoietic cells than in corresponding non-malignant
CC       cells. {ECO:0000269|PubMed:14576828}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class dual specificity subfamily. {ECO:0000305}.
CC   -!- CAUTION: An out-of-frame translation product, PYST2SB, has been
CC       experimentally demonstrated to be formed from the alternative
CC       promoter. The expression of the in-frame product has not yet been
CC       shown. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF508727; AAM77606.1; -; mRNA.
DR   EMBL; AF508728; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC115284; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL556300; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC019107; AAH19107.2; -; mRNA.
DR   EMBL; BC104880; AAI04881.1; -; mRNA.
DR   EMBL; BC104882; AAI04883.1; -; mRNA.
DR   EMBL; X93921; CAA63814.1; -; mRNA.
DR   CCDS; CCDS33766.2; -. [Q16829-1]
DR   RefSeq; NP_001938.2; NM_001947.3. [Q16829-1]
DR   UniGene; Hs.591664; -.
DR   PDB; 4Y2E; X-ray; 1.67 A; A/B/C/D=240-388.
DR   PDBsum; 4Y2E; -.
DR   ProteinModelPortal; Q16829; -.
DR   SMR; Q16829; -.
DR   BioGrid; 108182; 8.
DR   IntAct; Q16829; 8.
DR   STRING; 9606.ENSP00000417183; -.
DR   DEPOD; Q16829; -.
DR   iPTMnet; Q16829; -.
DR   PhosphoSitePlus; Q16829; -.
DR   BioMuta; DUSP7; -.
DR   DMDM; 338817906; -.
DR   MaxQB; Q16829; -.
DR   PaxDb; Q16829; -.
DR   PeptideAtlas; Q16829; -.
DR   PRIDE; Q16829; -.
DR   TopDownProteomics; Q16829-2; -. [Q16829-2]
DR   DNASU; 1849; -.
DR   Ensembl; ENST00000495880; ENSP00000417183; ENSG00000164086. [Q16829-1]
DR   GeneID; 1849; -.
DR   KEGG; hsa:1849; -.
DR   UCSC; uc003dct.4; human. [Q16829-1]
DR   CTD; 1849; -.
DR   DisGeNET; 1849; -.
DR   GeneCards; DUSP7; -.
DR   H-InvDB; HIX0003343; -.
DR   HGNC; HGNC:3073; DUSP7.
DR   MIM; 602749; gene.
DR   neXtProt; NX_Q16829; -.
DR   OpenTargets; ENSG00000164086; -.
DR   PharmGKB; PA27530; -.
DR   eggNOG; KOG1717; Eukaryota.
DR   eggNOG; COG2453; LUCA.
DR   GeneTree; ENSGT00760000118902; -.
DR   HOGENOM; HOG000294079; -.
DR   HOVERGEN; HBG007347; -.
DR   InParanoid; Q16829; -.
DR   KO; K04459; -.
DR   OMA; KFVKRCK; -.
DR   OrthoDB; EOG091G0249; -.
DR   PhylomeDB; Q16829; -.
DR   TreeFam; TF105122; -.
DR   Reactome; R-HSA-112409; RAF-independent MAPK1/3 activation.
DR   Reactome; R-HSA-202670; ERKs are inactivated.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   SIGNOR; Q16829; -.
DR   GeneWiki; DUSP7; -.
DR   GenomeRNAi; 1849; -.
DR   PRO; PR:Q16829; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000164086; -.
DR   CleanEx; HS_DUSP7; -.
DR   ExpressionAtlas; Q16829; baseline and differential.
DR   Genevisible; Q16829; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; TAS:Reactome.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; TAS:Reactome.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB.
DR   CDD; cd00127; DSPc; 1.
DR   Gene3D; 3.40.250.10; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR024950; DUSP.
DR   InterPro; IPR008343; MKP.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR10159; PTHR10159; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   Pfam; PF00581; Rhodanese; 1.
DR   PIRSF; PIRSF000939; MAPK_Ptase; 1.
DR   PRINTS; PR01764; MAPKPHPHTASE.
DR   SMART; SM00195; DSPc; 1.
DR   SMART; SM00450; RHOD; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF52821; SSF52821; 1.
DR   PROSITE; PS50206; RHODANESE_3; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Complete proteome;
KW   Cytoplasm; Hydrolase; Polymorphism; Protein phosphatase;
KW   Reference proteome.
FT   CHAIN         1    419       Dual specificity protein phosphatase 7.
FT                                /FTId=PRO_0000094807.
FT   DOMAIN       68    187       Rhodanese. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00173}.
FT   DOMAIN      308    376       Tyrosine-protein phosphatase.
FT   COMPBIAS    192    240       Ser-rich.
FT   ACT_SITE    331    331       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     51       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14603440}.
FT                                /FTId=VSP_012822.
FT   VARIANT     235    235       S -> N (in dbSNP:rs34821455).
FT                                /FTId=VAR_051752.
FT   STRAND      246    249       {ECO:0000244|PDB:4Y2E}.
FT   STRAND      252    255       {ECO:0000244|PDB:4Y2E}.
FT   HELIX       257    260       {ECO:0000244|PDB:4Y2E}.
FT   HELIX       263    268       {ECO:0000244|PDB:4Y2E}.
FT   STRAND      271    276       {ECO:0000244|PDB:4Y2E}.
FT   STRAND      279    281       {ECO:0000244|PDB:4Y2E}.
FT   STRAND      287    290       {ECO:0000244|PDB:4Y2E}.
FT   STRAND      292    295       {ECO:0000244|PDB:4Y2E}.
FT   HELIX       307    309       {ECO:0000244|PDB:4Y2E}.
FT   HELIX       310    322       {ECO:0000244|PDB:4Y2E}.
FT   STRAND      326    330       {ECO:0000244|PDB:4Y2E}.
FT   STRAND      332    336       {ECO:0000244|PDB:4Y2E}.
FT   HELIX       337    349       {ECO:0000244|PDB:4Y2E}.
FT   HELIX       354    364       {ECO:0000244|PDB:4Y2E}.
FT   HELIX       372    385       {ECO:0000244|PDB:4Y2E}.
SQ   SEQUENCE   419 AA;  44957 MW;  434467AC16A3F8BA CRC64;
     MKNQLRGPPA RAHMSTSGAA AAGGTRAGSE PGAGSGSGAG TGAGAATGAG AMPCKSAEWL
     QEELEARGGA SLLLLDCRPH ELFESSHIET AINLAIPGLM LRRLRKGNLP IRSIIPNHAD
     KERFATRCKA ATVLLYDEAT AEWQPEPGAP ASVLGLLLQK LRDDGCQAYY LQGGFNKFQT
     EYSEHCETNV DSSSSPSSSP PTSVLGLGGL RISSDCSDGE SDRELPSSAT ESDGSPVPSS
     QPAFPVQILP YLYLGCAKDS TNLDVLGKYG IKYILNVTPN LPNAFEHGGE FTYKQIPISD
     HWSQNLSQFF PEAISFIDEA RSKKCGVLVH CLAGISRSVT VTVAYLMQKM NLSLNDAYDF
     VKRKKSNISP NFNFMGQLLD FERTLGLSSP CDNHASSEQL YFSTPTNHNL FPLNTLEST
//
